Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Retapamulin 10 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Sodium fusidate 20 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
takalcitol (som takalcitolmonohydrat) 4 mikrogram/gram, kutan salva |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely salicylic acid 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
salicylsyra 60 % i vitt mjukt paraffin 40 %, salva |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
klortetracyklinhydroklorid 3 %, salva |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Nystatin 100000 unit/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
gentamicinsulfat 0,1 %, salva |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Nystatin 100 unit/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
erytromycin 20 mikrogram/milligram, kutan salva |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Bacitracin 500 unit/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Prednicarbate 1 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
mikonazol 0,25 % / zinkoxid 15 % / vitt vaselin 81,35 %, salva för lokalt bruk |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone dipropionate) 500 microgram/g and calcipotriol 50 microgram/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
katekin 15 %, salva för lokalt bruk |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Dithranol 10 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely glyceryl trinitrate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Cod liver oil 114 mg/g and zinc oxide 380 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
kamomillextrakt 10,5 %, salva |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Hydrocortisone acetate 10 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely alclometasone dipropionate 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
betametason 0,1 %, salva |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
betametason (som betametasondipropionat) 500 nanogram/milligram, kutan salva |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Clobetasone butyrate 500 microgram/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely diflucortolone valerate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Diflucortolone valerate 3 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
fluokortolon 0,5 %, salva |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Mometasone furoate 1 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Fluticasone propionate 50 microgram/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Lithium succinate 80 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely mupirocin 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Povidone iodine 100 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely cinchocaine hydrochloride 11 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Clobetasol propionate 500 microgram/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Hydrocortisone 10 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely benzalkonium chloride 1 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Hydrocortisone 5 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Neomycin 5 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Cinchocaine 10 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
betametasondipropionat 0,5 mg/g, salva |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Triamcinolone acetonide 1 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Fludroxycortide 250 microgram/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Fludroxycortide 500 microgram/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Amcinonide 1 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely chloramphenicol (as chloramphenicol sodium succinate) 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Desonide 500 microgram/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Halcinonide 1 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Desoximetasone 2.5 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Hydrocortisone valerate 2 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Erythromycin 5 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
betametasondipropionat 0,5 %, salva |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Aciclovir 50 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely heparinoid 8 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
lidokain 5 % + hydrokortisonacetat 0,275 %, salva |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
takrolimus (som takrolimusmonohydrat) 300 mikrogram/gram, kutan salva |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
takrolimus (som takrolimusmonohydrat) 1 milligram/gram, kutan salva |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely calcitriol 3 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
lidokain 2,5 %, salva för lokalt bruk |
Has manufactured dose form |
False |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely salicylic acid 600 milligram/1 gram and white petrolatum 400 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Tetracycline 10 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Betamethasone (as betamethasone dipropionate) 5 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Miconazole nitrate 2.5 mg/g and zinc oxide 150 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Lidocaine hydrochloride 25 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely chlortetracycline 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Fluocortolone caproate 2.5 mg/g and fluocortolone pivalate 2.5 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Gentamicin (as gentamicin sulfate) 1 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely betamethasone valerate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Crisaborole 20 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Tirbanibulin 10 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely tacrolimus 300 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely tacrolimus 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely tacalcitol 4 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely clobetasol propionate 500 microgram/1 gram and gentamicin (as gentamicin sulfate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Lysine hydrochloride 150 mg/g cutaneous ointment |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|
Product containing precisely miconazole nitrate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
True |
Cutaneous ointment |
Inferred relationship |
Some |
|